Our Patents

SCYNEXIS U.S. patent rights for products

In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies SCYNEXIS’s rights in U.S. patents associated with the relevant product. This list may be a subset of SCYNEXIS’s rights in U.S. patents directed to the relevant product.

BREXAFEMME® (ibrexafungerp tablets)

  • U.S. Patent No. 8,188,085
  • U.S. Patent No. 10,174,074
  • U.S. Patent No. 10,370,406
  • U.S. Patent No. 10,927,142
  • U.S. Patent No. 11,534,433